amlodipine 2.5 MG Oral Tablet [Norvasc]
- RxCUI
- 212542
- RxNorm name
- amlodipine 2.5 MG Oral Tablet [Norvasc]
- Display name
- amlodipine 2.5 MG Oral Tablet [Norvasc]
- Full name
- amlodipine 2.5 MG Oral Tablet [Norvasc]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:15
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | 212542 |
| Norvasc | AMLODIPINE BESYLATE | PFIZER LABORATORIES DIV PFIZER INC | abd6a2ca-40c2-485c-bc53-db1c652505ed | 2019-01-15 | Warnings, Adverse reactions | 212542 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| abd6a2ca-40c2-485c-bc53-db1c652505ed | Norvasc 2.5 MG Oral Tablet [PSN] · amlodipine 2.5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 2.5 MG Oral Tablet [SY] · Norvasc 2.5 MG Oral Tablet [SY] | 4 | 29 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | 20190115 |
| 7367289c-b0b0-466a-83e2-558e2985c29f | Norvasc 2.5 MG Oral Tablet [PSN] · amlodipine 2.5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 2.5 MG Oral Tablet [SY] · Norvasc 2.5 MG Oral Tablet [SY] | 4 | 10 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | 20230215 |